Literature DB >> 16082501

Almost all about citrulline in mammals.

E Curis1, I Nicolis, C Moinard, S Osowska, N Zerrouk, S Bénazeth, L Cynober.   

Abstract

Citrulline (Cit, C6H13N3O3), which is a ubiquitous amino acid in mammals, is strongly related to arginine. Citrulline metabolism in mammals is divided into two fields: free citrulline and citrullinated proteins. Free citrulline metabolism involves three key enzymes: NO synthase (NOS) and ornithine carbamoyltransferase (OCT) which produce citrulline, and argininosuccinate synthetase (ASS) that converts it into argininosuccinate. The tissue distribution of these enzymes distinguishes three "orthogonal" metabolic pathways for citrulline. Firstly, in the liver, citrulline is locally synthesized by OCT and metabolized by ASS for urea production. Secondly, in most of the tissues producing NO, citrulline is recycled into arginine via ASS to increase arginine availability for NO production. Thirdly, citrulline is synthesized in the gut from glutamine (with OCT), released into the blood and converted back into arginine in the kidneys (by ASS); in this pathway, circulating citrulline is in fact a masked form of arginine to avoid liver captation. Each of these pathways has related pathologies and, even more interestingly, citrulline could potentially be used to monitor or treat some of these pathologies. Citrulline has long been administered in the treatment of inherited urea cycle disorders, and recent studies suggest that citrulline may be used to control the production of NO. Recently, citrulline was demonstrated as a potentially useful marker of short bowel function in a wide range of pathologies. One of the most promising research directions deals with the administration of citrulline as a more efficient alternative to arginine, especially against underlying splanchnic sequestration of amino acids. Protein citrullination results from post-translational modification of arginine; that occurs mainly in keratinization-related proteins and myelins, and insufficiencies in this citrullination occur in some auto-immune diseases such as rheumatoid arthritis, psoriasis or multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082501     DOI: 10.1007/s00726-005-0235-4

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  135 in total

1.  Plasma citrulline as marker of bowel adaptation in children with short bowel syndrome.

Authors:  Antonella Diamanti; Fabio Panetta; Paolo Gandullia; Francesco Morini; Cristian Noto; Giuliano Torre; Antonella Lezo; Bianca Goffredo; Antonella Daniele; Manuela Gambarara
Journal:  Langenbecks Arch Surg       Date:  2011-06-01       Impact factor: 3.445

2.  Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.

Authors:  Erin Gatza; Daniel R Wahl; Anthony W Opipari; Thomas B Sundberg; Pavan Reddy; Chen Liu; Gary D Glick; James L M Ferrara
Journal:  Sci Transl Med       Date:  2011-01-26       Impact factor: 17.956

3.  Determination of dimethylarginine dimethylaminohydrolase activity in the kidney.

Authors:  Y-L Tain; C Baylis
Journal:  Kidney Int       Date:  2007-07-25       Impact factor: 10.612

4.  Citrulline protects Streptococcus pyogenes from acid stress using the arginine deiminase pathway and the F1Fo-ATPase.

Authors:  Zachary T Cusumano; Michael G Caparon
Journal:  J Bacteriol       Date:  2015-02-02       Impact factor: 3.490

5.  Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.

Authors:  Qiuying Chen; Kathryne Kirk; Yevgeniya I Shurubor; Dazhi Zhao; Andrea J Arreguin; Ifrah Shahi; Federica Valsecchi; Guido Primiano; Elizabeth L Calder; Valerio Carelli; Travis T Denton; M Flint Beal; Steven S Gross; Giovanni Manfredi; Marilena D'Aurelio
Journal:  Cell Metab       Date:  2018-04-12       Impact factor: 27.287

6.  Arginine and citrulline for the treatment of MELAS syndrome.

Authors:  Ayman W El-Hattab; Mohammed Almannai; Fernando Scaglia
Journal:  J Inborn Errors Metab Screen       Date:  2017-03-24

7.  Glucagon-like peptide-2 (GLP-2) increases net amino acid utilization by the portal-drained viscera of ruminating calves.

Authors:  C C Taylor-Edwards; D G Burrin; N B Kristensen; J J Holst; K R McLeod; D L Harmon
Journal:  Animal       Date:  2012-05-09       Impact factor: 3.240

8.  Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.

Authors:  Tawnya L Bowles; Randie Kim; Joseph Galante; Colin M Parsons; Subbulakshmi Virudachalam; Hsing-Jien Kung; Richard J Bold
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

9.  Plasma citrulline kinetics and prognostic value in critically ill patients.

Authors:  Gaël Piton; Cyril Manzon; Elisabeth Monnet; Benoit Cypriani; Olivier Barbot; Jean-Christophe Navellou; Franck Carbonnel; Gilles Capellier
Journal:  Intensive Care Med       Date:  2010-04       Impact factor: 17.440

10.  Alterations in glutamine metabolism and its conversion to citrulline in sepsis.

Authors:  Christina Kao; Jean Hsu; Venkata Bandi; Farook Jahoor
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-23       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.